Assay

Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2

Friday, January 15, 2021 - 6:30am

Currently, strains of concern include the B.1.1.7 variant, first identified in the United Kingdom, and the B.1.351 variant, first identified in South Africa.

Key Points: 
  • Currently, strains of concern include the B.1.1.7 variant, first identified in the United Kingdom, and the B.1.351 variant, first identified in South Africa.
  • Furthermore, this RT-PCR test maintains very high sensitivity in the detection of variants such as B.1.1.7 and B.1.351.
  • Eurofins ability to produce and distribute primers and probes, and commercial PCR kits, additionally benefits the speed of development of new assays.
  • With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins companies offer a portfolio of over 200,000 analytical methods.

Blackrock Core Drilling Confirms Thick Vein at Victor Target Reporting Multiple Significant Intercepts and Outlines 2021 Exploration Program at Tonopah West

Thursday, January 14, 2021 - 1:00pm

Vancouver, British Columbia--(Newsfile Corp. - January 14, 2021) - Blackrock Gold Corp.(TSXV: BRC)(the "Company") is pleased to announce more high-grade gold and silver drill intercepts from its core drilling program on the Victor Target on the 100% controlled Tonopah West project located in the Walker Lane trend of Western Nevada.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - January 14, 2021) - Blackrock Gold Corp.(TSXV: BRC)(the "Company") is pleased to announce more high-grade gold and silver drill intercepts from its core drilling program on the Victor Target on the 100% controlled Tonopah West project located in the Walker Lane trend of Western Nevada.
  • These results validate the Company's understanding of the structural orientation of the thick structure that was previously encountered during reverse circulation drilling and highlights considerable geologic potential within this target area.
  • With our geologic model now validated, it is evident that significant exploration potential remains within this target.
  • Table 1: Summary of significant Au and Ag assay results using a 200 g/t AgEq cut-off grade.

Benchmark Drills New Discovery Yielding 101 Metres of 0.82 g/t Gold Equivalent, Including 2 Metres of 14.52 g/t Gold Equivalent

Wednesday, January 13, 2021 - 2:15pm

Drill targeting at the Marmot zone was initiated following systematic geological work that indicates a highly prospective region measuring 2 by 3 kilometres.

Key Points: 
  • Drill targeting at the Marmot zone was initiated following systematic geological work that indicates a highly prospective region measuring 2 by 3 kilometres.
  • The Target has not been evaluated for reasonable prospects for future economic extraction as metallurgical work and drilling are planned and ongoing.
  • Gold was assayed using a fire assay with atomic emission spectrometry and gravimetric finish when required (+10 g/t Au).
  • Benchmark is managed by proven resource sector professionals, who have a track record of advancing exploration projects from grassroots scenarios through to production.

LexaGene Initiates Program to Identify UK and South African COVID Sequences

Wednesday, January 13, 2021 - 1:43pm

LexaGene is pursuing FDA EUA for COVID-19 testing using assays that are predicted to detect >99.9% of the strains circulating today based on published sequences, including the UK and South African variants.

Key Points: 
  • LexaGene is pursuing FDA EUA for COVID-19 testing using assays that are predicted to detect >99.9% of the strains circulating today based on published sequences, including the UK and South African variants.
  • Dr. Regan continues, We founded LexaGene to fill a critical technology gap in our defenses against new pathogens.
  • LexaGene has designed and ordered components for tests to distinguish the UK and South African strains from the traditional coronavirus strain and will confirm these work as expected on the MiQLab system.
  • The MiQLab system delivers excellent sensitivity, specificity, and breadth of detection and can return results in approximately one hour.

Luminex Commences Condor PEA and Intercepts 4.0 Meters of 7.1 g/t Gold at the Camp Deposit

Tuesday, January 12, 2021 - 12:00pm

Logging and sampling are completed at Luminex's core handling facility located at the Condor property.

Key Points: 
  • Logging and sampling are completed at Luminex's core handling facility located at the Condor property.
  • Sample pulps are sent to ALS's lab in Lima, Peru for analysis where gold content is determined by fire assay of a 50-gram charge with ICP finish.
  • In the future all samples from the Camp deposit area grading greater than 0.5 g/t gold will be re-analyzed via the metallic-screen technique.
  • Over-limit samples assaying greater than 10 g/t gold and 100 g/t silver are re-analyzed by ALS using screen fire assay with a gravimetric finish.

Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling

Monday, January 11, 2021 - 7:05pm

TruSight Oncology 500 (TSO 500) is a Research Use Only comprehensive pan-cancer assay designed to identify 523 known and emerging tumor biomarkers.

Key Points: 
  • TruSight Oncology 500 (TSO 500) is a Research Use Only comprehensive pan-cancer assay designed to identify 523 known and emerging tumor biomarkers.
  • Based on the content of TSO 500, Illumina will be adding an in vitro diagnostic (IVD) test to the TruSight Oncology product family.
  • This comprehensive tumor profiling assay will have similar chemistry and analytics to TSO 500 and is currently undergoing review with regulatory authorities.
  • MERCK: Additionally, Illumina and Merck are conducting a study focused on the expanded TruSight Oncology HRD offering.

50 Meter Step-Out Hole at Keats Intercepts Broad, Shallow, High-Grade Intervals: 22.5 g/t Au over 10.4m and 31.4 g/t Au over 15.9m

Monday, January 11, 2021 - 1:00pm

Assays are uncut, and calculated intervals are reported over a minimum length of 2 meters using a lower cutoff of 1.0 g/t Au.

Key Points: 
  • Assays are uncut, and calculated intervals are reported over a minimum length of 2 meters using a lower cutoff of 1.0 g/t Au.
  • The whole sample metallic screen assay method is selected by the geologist when samples contain coarse gold or any samples displaying gold initial fire assay values greater than 1.0 g/t Au.
  • Standards and blanks are included with every 20 samples for Quality Assurance/Quality Control purposes by the Company as well as the lab.
  • Our management has a pledge to be in touch with any investor inquiries within 24 hours.

U.S. FDA Lists Applied DNA’s Linea™ COVID-19 Assay Kit as 1 of Only 2 EUA-Authorized Tests Able to Detect S-Gene Mutation Found in SARS-CoV-2 U.K. Variant (B.1.1.7)

Friday, January 8, 2021 - 6:43pm

According to the Communication, the FDA monitors the potential effects of genetic variation on molecular tests that have received EUA, including the Companys Assay Kit.

Key Points: 
  • According to the Communication, the FDA monitors the potential effects of genetic variation on molecular tests that have received EUA, including the Companys Assay Kit.
  • The Communication notes that molecular tests designed to detect multiple SARS-CoV-2 genetic targets, such as the Assay Kit, are less susceptible to the effects of genetic variation than tests designed to detect a single genetic target.
  • The Communication notes that the reduced sensitivity, also known as an S-gene dropout, may be indicative of certain SARS-CoV-2 mutations, including the B.1.1.7 variant.
  • Due to the Assay Kits multi-target design, the Communication states the Assay Kits overall sensitivity should not be impacted.

Global Cell Viability Assays Market- Featuring Agilent Technologies Inc., Becton, and Dickinson and Co. Among Others | Technavio

Wednesday, January 6, 2021 - 9:28pm
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210106005860/en/
    Technavio has announced its latest market research report titled Global Cell Viability Assays Market 2020-2024 (Graphic: Business Wire)
    Worried about the impact of COVID-19 on your Business?
  • The report on the cell viability assays market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The cell viability assays market analysis includes Product segment and Geography Landscape.
  • This study identifies the growing focus on stem cell research as one of the prime reasons driving the cell viability assays market growth during the next few years.

Adeptrix Closes Series A Financing to Commercialize BAMS™ Bioanalytical Reagents for Life Science Research

Wednesday, January 6, 2021 - 9:16pm

The proceeds will go toward accelerating commercialization of multiple BAMS products and establishing custom BAMS assay development service for pharma, clinical, and food-science customers.

Key Points: 
  • The proceeds will go toward accelerating commercialization of multiple BAMS products and establishing custom BAMS assay development service for pharma, clinical, and food-science customers.
  • Adeptrix has recently entered into several research collaborations, leveraging its unique approach, to develop tools for accurate, rapid and easy-to-use COVID-19 diagnostics.
  • Adeptrix BAMS technology is a multiplexed immunoassay platform for targeted analysis of proteins and protein fragments by MALDI-TOF mass spectrometry.
  • Adeptrix will develop and commercialize BAMS assay kits for virology research and clinical diagnostics, both directly and via its strategic partners worldwide sales and marketing teams.